ARMISTICE CAPITAL LLC 13D/13G Filings for Paratek Pharmaceuticals, Inc. (PRTK)

ARMISTICE CAPITAL LLC 13D and 13G filings for Paratek Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-02-14
3:28 pm
Sale
2020-02-1413GParatek Pharmaceuticals, Inc.
PRTK
ARMISTICE CAPITAL LLC1,258,000
3.800%
-710,000decrease
(-36.08%)
Filing